NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2025
Back to search
Official data from USPTO
ARTHRAMIDVET
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
12/09/2025
Classification
Registered
Trademark type
Combined
Nice classes
5, 10
Filing date
05/26/2023
Registration date
12/09/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/09/2025
Last transaction
12/09/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/30/2023
First use in commerce
11/30/2023
Drawing code
3
Owner type
99
Owner location
Dublin 2, D02 X576, IE
Examiner
ORDOGNE, ROBERT J
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word ARTHRAMIDVET in purple stylized font, appearing over a wavy line in various shades of purple. The letter R in the word ARTHRAMIDVET extends into the purple wavy line, appearing in white.
Holders and representatives
Holders
Contura Vet Limited
Representatives
Julia Anne Matheson POTOMAC LAW GROUP, PLLC
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Injectable surgical gels for veterinary use for the treatment of domestic animals for the treatment of arthritisbone diseases and joint diseases; injectable gels for surgical use for the treatment of arthritisbone diseases and joint diseases; injectable surgical implants in the form of living tissue for veterinary use; injectable gels for the treatment of arthritis in domestic animals; injectable implants in the form of living tissue for the treatment of arthritis in vertebrates
Class 10
Veterinary and surgical implants made of artificial material; injectable implants made of artificial material for surgical use; injectable implants made of artificial material for the treatment of arthritis
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/20/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/20/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/23/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/22/2025
IUAF
USE AMENDMENT FILED
05/16/2025
EISU
TEAS STATEMENT OF USE RECEIVED
05/16/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2024
PUBO
PUBLISHED FOR OPPOSITION
10/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/26/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/22/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
05/14/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
05/14/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/22/2024
GNRT
NON-FINAL ACTION E-MAILED
02/22/2024
CNRT
NON-FINAL ACTION WRITTEN
02/22/2024
DOCK
ASSIGNED TO EXAMINER
02/20/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/28/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/27/2023
NWAP
NEW APPLICATION ENTERED
05/30/2023
Continuous trademark protection
Get notified about every new filing that threatens ARTHRAMIDVET or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.